Expert Opinion on Drug Discovery

Aims & Scope

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates.

Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome: Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.9
2024	6.00

SJR (SCImago Journal Rank)

Year	Value
2024	1.195

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	90

Journal Rank

Year	Value
2024	3574

Journal Citation Indicator

Year	Value
2024	1843

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities

  Citation: 4066

  Authors: Samuel, Ulf

• Lipophilicity in drug discovery

  Citation: 751

  Authors: Michael J

• The influence of lipophilicity in drug discovery and design

  Citation: 679

  Authors: John A, Sonia Lobo

• Virtual screening with AutoDock: theory and practice

  Citation: 538

  Authors: Sandro, Stefano, Alex L, Rodney, David S, Arthur J

• Molecular dynamics simulations and novel drug discovery

  Citation: 427

  Authors: Xuewei, Danfeng, Shuangyan, Hongli, Huanxiang, Xiaojun

• Advances in structure-based drug discovery of carbonic anhydrase inhibitors

  Citation: 350

  Authors: Claudiu T.

• Fluorescence polarization assays in small molecule screening

  Citation: 324

  Authors: Wendy A, Anton

• Artificial intelligence in drug discovery: recent advances and future perspectives

  Citation: 310

  Authors: José, Francesca, Nils, Gisbert

• The importance of plasma protein binding in drug discovery

  Citation: 306

  Authors: George L

• An overview of molecular hybrids in drug discovery

  Citation: 284

  Authors: Gervais

---